| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Centre for Inflammatory Diseases,* Monash University, Victoria, Australia; and the Departments of Pediatrics, Microbiology-Immunology, and Pathology, Dalhousie University, Halifax, Nova Scotia, Canada
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
4-integrin expressed on specific leukocyte populations.1-5
Leukocyte adhesion is mediated by interaction of the leukocyte integrins including the ß2 and 4 integrins, with their respective endothelial ligands, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).6
Although there is significant evidence supporting the overall basis of this paradigm, the precise combination of adhesion molecules used in each response is highly diverse, and varies according to the type of response and the tissue examined. One type of inflammatory response in which the adhesion molecules responsible for leukocyte recruitment have not been fully characterized is immune complex (IC)-induced inflammation. ICs are thought to play critical roles in several immunological diseases, including systemic lupus erythematosus, vasculitis, glomerulonephritis, and rheumatoid arthritis. One of the mechanisms whereby ICs induce tissue injury is via their potent ability to induce leukocyte recruitment. The molecular mechanisms of IC-induced leukocyte recruitment have been examined in diverse tissues such as the lung, skin, and kidney, with correspondingly diverse results. Blockade of leukocyte ß2 integrins has been consistently observed to attenuate IC-induced leukocyte recruitment, presumably via inhibition of the adhesion step.7-9 However, analysis of the molecules responsible for the initial contact between the leukocytes and endothelial cells, ie, tethering and rolling, has generated less consistent data. In the lung, reagents that inhibit E-selectin and L-selectin, but not P-selectin, are effective in reducing IC-induced leukocyte recruitment.10-12 Conversely in the skin, all three (P-, E-, and L-) selectins have been implicated in the response,10,13,14 and in the kidney in models of IC-mediated glomerulonephritis, a role has been observed for P-selectin but not E-selectin.9,15 Finally, a recent study has raised the possibility that ICs themselves may be capable of initiating contact between leukocytes moving rapidly in flowing blood and activated endothelial cells lining the microvasculature.16
In many of these studies, more than one molecule has been implicated as mediating leukocyte rolling, although it remains unclear how these multiple rolling molecules interact to mediate recruitment. The existing studies have been hampered by the lack of direct visualization of the affected microvasculature. As leukocyte-endothelial interactions occur under the dynamic conditions of microvascular blood flow and involve interactions between moving and static cell populations, to accurately define roles of individual molecules it is necessary to directly visualize these interactions in vivo under normal blood flow conditions. Therefore the aim of these studies was to examine the functional adhesion molecule pathways in IC-induced leukocyte recruitment, by directly examining the affected microvasculature. To achieve this aim we applied the well-characterized reverse-passive Arthus (RPA) response to the mouse cremaster muscle, and examined the affected microvasculature using intravital microscopy. Using this approach we observed P-selectin-dependent rolling consistently throughout the first 8 hours of the RPA response, in addition to a period of overlapping E-selectin-dependent rolling between 2 to 5 hours after initiation of the RPA response. Furthermore, we observed that VCAM-1 played a critical role in the subsequent steps of adhesion and emigration.
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
C57BL/6 mice were bred in-house at Monash University or purchased from the Walter and Eliza Hall Institute, Melbourne, Australia, and housed in conventional conditions. P-selectin-/- mice on a C57BL/6 background were supplied by The Jackson Laboratory, Bar Harbor, ME, and housed in specific pathogen-free conditions.
Antibodies
The antibodies used in this study were polyclonal rabbit anti-OVA (anti-OVA) antibody (Sigma Chemical Co., St. Louis, MO); RB40.34, an IgG1 mAb against murine P-selectin (20 µg/mouse; BD Biosciences, San Diego, CA); RME-1, an IgG1 mAb against rat and mouse E-selectin (100 µg/mouse); RMP-1 a mAb against rat and mouse P-selectin (100 µg/mouse); 6C7.1 a mAb against murine VCAM-1 (90 µg/mouse, hybridoma generously provided by Drs. Dietmar Vestweber and Britta Engelhardt, Max Planck Institut, Muenster, Germany); and A110-1 (IgG1) or A110-2 (IgG2) (20 to 100 µg/mouse; BD Biosciences), rat anti-keyhole limpet hemocyanin (KLH) mAbs used as isotype control mAbs in intravital microscopy and adhesion molecule expression experiments. The doses of all function-blocking antibodies used have been shown previously to be effective in specifically blocking their respective target molecules in vivo.3,17,18 RB6-8C5 (anti-Gr-1), FA-11 (anti-CD68), and KT3 (anti-CD3) were purified from hybridoma supernatants.
RPA Protocol
The RPA response was used as a model of IC-induced leukocyte recruitment.19,20
Briefly, 500 µg of OVA (Sigma Chemical Co.), at 5 mg/ml in sterile saline, was injected intravenously via the tail vein. Immediately thereafter, 25 µl of polyclonal anti-OVA antibody (containing 
100 µg IgG) (Sigma Chemical Co.) was injected intrascrotally in 200 µl of sterile saline, adjacent to the cremasteric microvasculature. Control animals were treated with intrascrotal injections of 100 µg of nonspecific rabbit IgG and intravenous OVA as for RPA mice (OVA/rabbit IgG). Responses were subsequently assessed at various stages up to 24 hours after induction of the RPA response.
Intravital Microscopy
Intravital microscopy of the murine cremaster muscle was performed as previously described.17
Animals were anesthetized by intraperitoneal injection of a cocktail of 10 mg/kg of xylazine (Bayer Pharmaceuticals, Pymble, NSW, Australia) and 200 mg/kg of ketamine hydrochloride (Caringbah, NSW, Australia). The left jugular vein was cannulated to administer additional anesthetic and antibodies. The animal was placed on a thermocontrolled-heating pad (Fine Science Tools, Vancouver, BC, Canada), regulating the core temperature to 37°C. The cremaster muscle was dissected free of tissues and exteriorized onto an optically clear viewing pedestal. The muscle was cut longitudinally with a cautery and held flat against the pedestal by attaching silk sutures to the corners of the tissue. The muscle was then superfused with bicarbonate-buffered saline, and covered with a coverslip held in place with vacuum grease (Dow Corning, 
Crown Scientific, Scoresby, Australia).
The cremasteric microcirculation was visualized using an intravital microscope (Axioplan 2 Imaging; Carl Zeiss Australia) with a x20 objective lens (LD Achroplan 20X/0.40 NA, Carl Zeiss) and a x10 eyepiece. A color video camera (Sony SSC-DC50AP, Carl Zeiss) was used to project the images onto a calibrated monitor (Sony PVM-20N5E) and the images were recorded for playback analysis using a videocassette recorder (Panasonic NV-HS950; Klapp Electronics, Prahran, Vic., Australia) as previously described.21
One to four venules (25 to 40 µm in diameter) were selected in each experiment and to minimize variability, the same section of venule was observed throughout the experiment. Venular diameter and the number of rolling and adherent leukocytes were determined off-line during video playback analysis. Rolling leukocytes were defined as those cells moving at a velocity less than that of erythrocytes within a given vessel. Leukocyte rolling velocity was determined by measuring the time required for a leukocyte to roll along a 100-µm length of venule. Rolling velocity was determined for 20 leukocytes at each time interval. Leukocytes were considered adherent to the venular endothelium if they remained stationary for 30 seconds or longer. Leukocyte emigration was defined as the number of extravascular leukocytes visible per microscopic field centered on a postcapillary venule, and was determined by averaging data derived from four to five fields. Centerline red blood cell velocity (VRBC) was measured on-line using an optical Doppler velocimeter (Microcirculation Research Institute, Texas A&M University, College Station, TX) and mean red blood cell velocity (VMEAN) was determined as VRBC/1.6. Venular wall shear rate (
) was calculated based on the Newtonian definition: = 8 (VMEAN/Dv).22
Experimental Protocol
In the initial series of experiments, leukocyte-endothelial cell interactions in the cremasteric microvasculature were examined 4, 8, and 24 hours after induction of the RPA response. These experiments revealed that peak levels of interactions were observed 4 hours after initiation of the response. Therefore to determine the roles of the endothelial selectins in mediating leukocyte rolling associated with this response, additional mice underwent the RPA protocol and were subsequently treated with function-blocking antibodies to P-selectin and E-selectin at various stages between 2.5 to 5 hours after initiation of the response. The effect of these treatments on leukocyte rolling was assessed. To reveal any P-selectin-independent leukocyte rolling throughout the first 5 hours of the response, in additional groups of mice P-selectin was inhibited continuously for the entire response, by intravenous dosing with 40 µg of RB40.34 at the same time as the OVA administration. Pilot experiments revealed that this treatment was effective in preventing rolling in cremasteric postcapillary venules in naïve mice for 4 to 5 hours. Some of these animals were also treated with RME-1 during the course of the experiment, to establish the role of E-selectin in mediating P-selectin-independent rolling in this response. An additional approach to assessing the role of P-selectin, E-selectin, and VCAM-1 in the RPA response was to examine P-selectin-/- mice under a range of conditions. P-selectin-/- mice were examined after undergoing the RPA response alone, or with RME-1, or RME-1 and 6C7.1 administered at the commencement of the response. Finally to assess the role of VCAM-1 alone, wild-type mice were treated with 6C7.1 at the commencement of the RPA response and examined 4 hours later.
In Vivo Assessment of Immune Complex Formation
To examine the location and timing of IC formation, fluorochrome-conjugated OVA (Alexa 488 OVA; Molecular Probes, Eugene, OR) and fluorochrome-conjugated anti-OVA (Alexa Fluor 594, conjugated according to the manufacturer’s instructions; Molecular Probes) were used to initiate the RPA response. In these animals, the response in the cremaster muscle was visualized via fluorescence microscopy. The tissue distribution of Alexa 488-conjugated OVA was determined by epi-illumination at 450 to 490 nm, with a 515-nm emission filter (Carl Zeiss filter set 09). Localization of Alexa 594-conjugated anti-OVA was assessed using a 530- to 585-nm excitation filter, with a 615-nm emission filter (Carl Zeiss filter set 00). In some animals, Alexa 488-conjugated OVA alone was used, to assess the distribution of systemically injected OVA in the absence of anti-OVA.
Tissues from these experiments were then snap-frozen in OCT embedding medium and prepared for confocal microscopy as previously described.23 Cryostat sections (6 µm) were prepared and mounted in anti-fade fluorescence-mounting media (DAKO, NSW, Australia), in the absence of fixation. Confocal images were collected using a confocal inverted Nikon Diaphot 300 microscope (Bio-Rad, Hercules, CA) equipped with an air-cooled 25-mW argon/krypton laser (excitation at 488 and 586 nm), as previously described.23 Digital images were collected using Bio-Rad Laser Sharp 2000 version 4.1 software.
Quantitation of Endothelial Adhesion Molecule Expression
Expression of P- and E-selectin was quantitated using a method adapted from Piccio and colleagues.24 RMP-1 (anti-P-selectin) was conjugated with Alexa Fluor 488 (Molecular Probes), according to the manufacturer’s instructions. In addition, as a nonspecific control IgG, anti-KLH antibody (BD Biosciences) was conjugated with Alexa 594. In microscopy experiments, Alexa 488/594-conjugated mAbs were visualized as for the similarly labeled molecules described above. Images were visualized using a SIT video camera (Dage-MTI VE-1000; Sci Tech Pty. Ltd., Preston South, Vic., Australia) on predefined gain and black level settings, and recorded for subsequent playback analysis using a videocassette recorder.
Mice underwent the RPA protocol as detailed above. At the end of the experimental period, mice were anesthetized, the right carotid artery and left jugular vein were cannulated, and the cremaster muscle prepared for microscopy. Recordings of background fluorescence detectable in the cremaster preparation were made for each of the excitation wavelengths, and these data were subtracted from all subsequent intensity readings. Then, to detect P-selectin expression, mice received 100 µg of RMP-1ALEXA 488 (a dose previously determined to saturate available receptors) and 20 µg of anti-KLHALEXA 594 intravenously. This ratio of binding mAb to nonbinding mAb is similar to that used in previous experiments examining selectin expression in vivo.25 Despite the difference in the amount of each antibody administered, binding of the specific antibody to its target antigen throughout the animal reduces its concentration in the circulation meaning that the levels of the two mAbs in the plasma are relatively similar. Moreover, irrespective of the relative amounts of circulating antibody, the final level of accumulation of each mAb is expressed relative to its own initial loading within the microvasculature. The microcirculation was visualized 1 to 2 minutes after administration of the mAbs and recorded at each excitation wavelength, to determine the initial level of each fluorochrome-conjugated mAb in the circulation. Antibodies were allowed to circulate for 5 minutes, and then the mouse was exsanguinated via the carotid artery cannula with simultaneous perfusion of bicarbonate-buffered saline via the jugular vein. An additional 10 ml of buffer was subsequently backflushed through the carotid artery after severing the abdominal vena cava. The microcirculation was then revisualized to detect selectin expression.
P-selectin expression was quantitated in two ways. Firstly the length of vessel containing specific (RMP-1ALEXA 488) labeling in the absence of nonspecific (anti-KLHALEXA 594) labeling was determined for 10 to 15 sequential x10 (Achroplan 10X/0.25 NA) fields. Individual video frames were captured from videotape as previously described,26 and analyzed using Scion Image analysis software (Scion Corp., Frederick, MD). These data were expressed as mm-positive vessel/mm2 tissue area. Secondly, the intensity of staining in individual vessels was determined, using a x20 objective lens (LD Achroplan 20X/0.40 NA, Carl Zeiss). To assess this parameter, the degree of nonspecific antibody accumulation was first determined by measuring the intensity of Alexa 594-associated fluorescence remaining after exsanguination, and expressing this as a percentage of the initial loading of this fluorochrome in the vessel. The intensity of Alexa 488-derived fluorescence (RMP-1) associated with the vascular wall was then measured. These data were then reduced by the percentage binding of the control antibody, to account for the contribution of nonspecific antibody accumulation, and the data expressed as intensity units. Previous experiments using radiolabeled antibodies to quantitate adhesion molecule expression in vivo have used a comparable approach to account for nonspecific accumulation of antibodies in the vasculature.25,27 This technique revealed constitutive expression of P-selectin, in the cremasteric microvasculature in accord with previous observations.25,28
Because the P-selectin experiments revealed that nonspecific antibody accumulation in this assay was minimal, E-selectin expression was assessed using a specific antibody only (RME-1ALEXA 594, 100 µg). Using this approach, constitutive expression of E-selectin was detectable in some dermal microvessels but absent in the cremaster muscle, in accord with previous observations.28-30
Immunohistochemical Identification of Infiltrating Leukocytes and C3 Deposition
Leukocytes present in cremaster muscles after RPA challenge were identified using a three-layer immunoperoxidase technique according to a previously published technique.31 Cremaster muscles were fixed in periodate/lysine/paraformaldehyde, cryoprotected in 7% sucrose/phosphate-buffered saline, and frozen over liquid nitrogen. Eight-µm sections were prepared on a cryostat, and individual sections stained using RB6-8C5 (anti-Gr-1) to demonstrate neutrophils, FA-11 (anti-CD68) for monocytes/macrophages, and KT3 (anti-CD3) to demonstrate T lymphocytes.31 The level of recruitment of each of these cell types was assessed semiquantitatively, using a 0 to 3 scale. Similarly fixed sections were stained for C3 deposition by direct staining with fluorescein isothiocyanate-conjugated goat anti-mouse C3 (Cappel Laboratories/ICN Biomedicals Australasia, Seven Hills, NSW, Australia). Sections were preincubated with 10% goat serum in 5% bovine serum albumin/phosphate-buffered saline (PBS) (10 minutes) then stained with anti-mouse C3 diluted 1:400 in 1% bovine serum albumin/PBS (30 minutes). Slides were washed in PBS and mounted in aqueous mounting medium.13
Statistical Analysis
All data are displayed as mean ± SEM. Initial comparisons across three to four groups were performed using one-way analysis of variance and Dunnett’s multiple comparison tests. For comparisons involving only two groups, Student’s t-tests were used. Paired analysis was used for comparison between before and after antibody treatments. A value of P < 0.05 was deemed significant.
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
In initial experiments we examined the formation of ICs during the RPA response in the cremaster muscle using an in vivo fluorescence microscopy approach (Figure 1)
. After intravenous injection of Alexa 488-conjugated OVA, OVA progressively exits the vasculature and distributes throughout the entire muscle. In the first 20 minutes, OVA is restricted to the perivascular area, in some cases in a localized pattern suggestive of cellular binding. However by 30 to 45 minutes after administration, OVA-derived fluorescence is widely distributed throughout the muscle tissue, apparently binding to cells throughout the muscle. Staining was excluded from muscle fibers (Figure 1A)
. When Alexa 594-conjugated anti-OVA antibody was superfused over the tissue at the same time as intravenous OVA injection, a different response was observed (Figure 1B)
. Within 10 minutes of OVA administration, large amounts of OVA were present in the perivenular tissue, suggestive of a rapid increase in vascular permeability. Indeed, whereas in the OVA-alone experiments, circulating OVA remained detectable in the vasculature for at least 40 minutes, in the presence of anti-OVA OVA was lost from the circulation much more rapidly. This is in accord with previous observations of a rapid increase in tissue edema in the initial stages of the RPA response.8
We also examined the distribution of Alexa 594-conjugated anti-OVA during the same period. Initially the anti-OVA was evenly distributed across the tissue. However, 20 minutes after initiation of the response localized regions of intense Alexa 594-derived fluorescence were present in perivenular areas, co-localized with OVA (Figure 1B)
. Examination of cryostat sections of these tissues via confocal microscopy revealed that 60 minutes after OVA administration, all OVA was co-localized with anti-OVA (Figure 1, C to E)
. A similar staining pattern was observed 4 hours after OVA administration (data not shown). Examination of C3 deposition 4 hours after RPA revealed a very similar distribution of staining, with localized C3 staining present both in perivascular regions and throughout the tissue (Figure 1G)
. Taken together, the co-localization of OVA and anti-OVA, as well as the spatially similar C3 deposition, suggest that ICs initially form in perivascular regions, associated with the initial exit of OVA from the vasculature. Subsequently ICs form throughout the tissue, both in perivascular regions, and at sites well away from the vasculature.
|
We next examined the alterations in leukocyte rolling, adhesion, and emigration in the cremasteric microvasculature induced by the RPA protocol. Table 1
shows venular diameters and microvascular shear rates in naïve, OVA/rabbit IgG, and RPA mice 4 hours after treatment. No significant differences were observed in these parameters. Four hours after initiation of the response, leukocyte rolling in OVA/rabbit IgG-treated mice was significantly elevated above levels in untreated mice (Figure 2A)
. However, leukocyte rolling flux in RPA-treated mice was not different from levels in untreated mice. In contrast to rolling flux, leukocyte rolling velocity was dramatically reduced both in RPA mice, and to a lesser extent in OVA/rabbit IgG mice (Table 1)
. Eight hours after RPA treatment, both leukocyte rolling flux and velocity returned to basal levels (data not shown) and remained at this level 24 hours after treatment. The most marked effects of the RPA treatment were discernable on examination of leukocyte adhesion and emigration. Four hours after RPA treatment, leukocyte adhesion and emigration were significantly elevated above levels in both untreated and OVA/rabbit IgG mice (Figure 2, B and C)
. Emigration was 25 cells/field at 4 hours. As seen with the rolling response, the increase in leukocyte adhesion had abated by 8 hours (not shown) and remained at basal levels at 24 hours. However significant numbers of leukocytes remained present in the tissue at 24 hours (Figure 2C)
. These observations indicated that this model of IC-induced inflammation was highly effective at inducing leukocyte recruitment into the cremaster muscle, as seen previously in other tissues.
|
|
. At 24 hours, the numbers of Gr-1+ leukocytes remained at a high level, whereas the number of FA-11+ cells was increased relative to the earlier time point. In 50% of the animals examined, small numbers of T lymphocytes were also present at 24 hours.
|
Given that previous studies have indicated a role for P- and E-selectin in IC-mediated leukocyte recruitment to other tissues, we next examined the effect of RPA treatment on expression of the endothelial selectins. P-selectin was expressed constitutively at low levels, in accord with our previous observations.28
However, this expression was only detectable in a low proportion of venules in the untreated cremaster muscle. In contrast, 4 hours after RPA treatment, P-selectin expression markedly increased (Figure 3)
. Direct analysis of the cremasteric microvasculature after labeling with RMP-1ALEXA 488 indicated that this increase in expression occurred as both an increase in the level of P-selectin expression in individual vessels (Figure 3C)
, and an increase in the number of venules expressing P-selectin (Figure 3D)
. A different pattern was observed for E-selectin expression. As previously documented, E-selectin was undetectable in untreated cremaster muscles.28
However, 4 hours after initiating the RPA response, E-selectin was clearly expressed (Figure 4)
, although the venular length found to be positive for E-selectin was 50% of that positive for P-selectin. After 8 hours, E-selectin expression had decreased, but remained detectable.
|
|
In the next series of experiments we used function-blocking mAbs to delineate the individual roles of the endothelial selectins in mediating leukocyte rolling after RPA. Administration of anti-P-selectin shortly after the 4-hour time point reduced leukocyte rolling by 80 to 90% (Figure 5A)
. Administration of nonbinding control antibody at the same time point had no significant effect on leukocyte rolling flux (data not shown). The residual P-selectin-independent rolling revealed by this protocol persisted until at least 5 hours after RPA. However, P-selectin blockade had no significant effect on leukocyte adhesion throughout this time course (Figure 5B)
. To clearly define the development of the P-selectin-independent leukocyte-endothelial cell interactions, we then examined the effect of P-selectin blockade throughout the entire RPA protocol. In RPA-treated animals, P-selectin antibody was administered intravenously at the same time as the OVA, at a dose shown in pilot studies to block leukocyte rolling in the cremaster muscle for at least 5 hours. Because it was not feasible to examine mice for longer than 2 hours, two groups of animals were examined: the first group covered the period between 2 to 4 hours after RPA, and the second were examined from 4 to 5 hours. These experiments revealed that significant P-selectin-independent rolling first developed 2 hours after RPA and increased to a peak of 25 to 30 cells/minute, between 2.5 to 4 hours (Figure 6A)
. This rolling had declined to minimal levels 5 hours after initiation of the RPA response (Figure 6B)
. In additional RPA-treated mice at 8 hours, P-selectin blockade eliminated leukocyte rolling, indicating that the P-selectin-independent rolling had ceased by this point (Figure 6E)
. No reduction in rolling was observed in wild-type mice treated with control nonblocking antibody at either 2 to 4 hours (data not shown) or 4 to 5 hours (Figure 6B)
. In contrast to the effect on rolling, leukocyte adhesion in mice undergoing continuous P-selectin blockade increased at the same rate as that observed in normal RPA-treated mice, indicating that the low level of P-selectin-independent rolling was sufficient to allow adhesion to reach levels achieved without P-selectin blockade (Figure 6, C and D)
.
|
|
Given that the time course of P-selectin-independent rolling mirrored that of E-selectin expression, we next examined the role of E-selectin in the response. Acute E-selectin blockade in wild-type RPA mice had no effect on leukocyte rolling flux or adhesion (data not shown). Moreover, pretreatment of mice with RME-1 at the start of the RPA response did not significantly alter leukocyte entry into the inflamed cremaster muscle [4 hours emigration: wild-type, 35.9 ± 7.5 cells/field (n = 10) versus continuous E-selectin blockade, 43 ± 8.4 cells/field (n = 4)]. These findings indicate that under conditions in which P-selectin-dependent rolling is unimpeded during the first 4 hours of the RPA response, continual E-selectin blockade does not reduce the ability of leukocytes to enter the inflamed site.
We next examined whether E-selectin mediated the P-selectin-independent rolling interactions seen in RPA-treated mice undergoing continuous P-selectin blockade. In these mice, E-selectin blockade at either 2.5 hours or 3 hours completely eliminated rolling. Furthermore, in P-selectin-inhibited mice treated with RME-1 at 3 hours, rolling continued to be completely inhibited at 4 hours (Figure 7A)
. The absence of rolling in animals undergoing combined blockade of P- and E-selectin resulted in a significant reduction in leukocyte adhesion at 3.5 and 4 hours relative to animals in which P-selectin alone was inhibited (Figure 7B)
. These findings demonstrate that the endothelial selectins combined to mediate all of the leukocyte rolling during this phase of the RPA response.
|
. Leukocyte adhesion, although not different from that in wild-type mice at 4 and 4.5 hours, was significantly reduced at 5 hours relative to levels in wild-type mice (Figure 8B)
. Despite this reduction in adhesion, leukocyte emigration in P-selectin-/- mice reached a comparable level to that in wild-type mice (Figure 8C)
. These observations confirm that P-selectin-mediated rolling was not required for leukocyte accumulation in the extravascular tissue to reach normal levels during the first 5 hours of the RPA response. To examine the combined role of P- and E-selectin throughout the entire course of the response, we treated P-selectin-/- mice with anti-E-selectin mAb at the initiation of RPA. These animals showed no detectable rolling between 4 to 5 hours. In addition this treatment resulted in a significant reduction in leukocyte adhesion at 4 and 4.5 hours, in contrast to the untreated P-selectin-/- animal. However even with this combined treatment, leukocyte emigration was not different from that in RPA-treated wild-type mice.
|
Given that adhesion and emigration continued to occur in RPA mice in which P-selectin was absent and E-selectin was inhibited, we investigated the role of VCAM-1 in mediating the ongoing adhesive interactions. Combined blockade of E-selectin and VCAM-1 in P-selectin-/- mice reduced adhesion to basal levels, and significantly reduced leukocyte emigration at 5 hours (Figure 9)
. These findings suggested a key role for VCAM-1 in the RPA response. Therefore in a final series of experiments we examined the effect of inhibiting VCAM-1 alone in wild-type RPA mice (Figure 10)
. VCAM-1 blockade throughout the entire response did not affect leukocyte rolling flux at 5 hours, although it did result in a significant increase in leukocyte rolling velocity at 4.5 hours (data not shown), indicating a possible role for VCAM-1 in supporting rolling. However, the most marked effects of this treatment were on leukocyte adhesion and emigration, both of which were significantly decreased after VCAM-1 blockade. Indeed, these parameters were reduced to such an extent that they were not different from levels in untreated mice. Control antibody treatment throughout the same time course had no discernable effect (shown in Figure 6B
). These data clearly illustrate that VCAM-1 plays a key role in mediating both adhesion and emigration in the RPA response.
|
|
|
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Previous data have used indirect techniques to implicate various combinations of the three selectin molecules in IC-induced leukocyte recruitment. In skin, either blockade of P-selectin alone or E-selectin alone has been shown to significantly reduce leukocyte entry.10,13 In contrast in the lung, inhibition of either E-selectin or L-selectin but not P-selectin has been shown to reduce leukocyte recruitment induced by IC formation.10-12,32 Finally, inhibition of P-selectin but not E-selectin has been shown to reduce IC-dependent leukocyte recruitment in models of glomerulonephritis believed to involve formation of ICs at the glomerular basement membrane.9,15 Much of this disparity may be explained by differing adhesion molecule requirements in different tissues. Recent studies have clearly demonstrated that identical inflammatory responses can use different combinations of adhesion molecules in different tissues.28,33,34 However the observations that in the skin, inhibition of either E-selectin or P-selectin alone dramatically reduces leukocyte recruitment raises the possibility that these two molecules are playing critical, yet nonoverlapping functions. Given that the types of leukocytes recruited by each of these molecules are similar,35 the mechanism for these apparently nonoverlapping functions is not clear. Under these circumstances, the ideal way of unequivocally identifying the role of each molecule is to directly visualize the inflamed microvasculature, as performed in the present experiments. Our findings indicate that in the cremasteric microvasculature during the period of E-selectin expression, the two endothelial selectins have overlapping rather than independent roles; ie, inhibition of only one molecule is insufficient to reduce rolling to the extent that the number of adherent cells is significantly affected.
ICs have also been shown to be capable of inducing endothelial VCAM-1 expression both in vitro and in dermal microvessels in vivo.36,37
However the present data further these observations by demonstrating a key functional role for VCAM-1 in leukocyte adhesion in the RPA response. Indeed, even in conditions in which selectin-mediated rolling was intact, VCAM-1 blockade reduced adhesion to levels not different from those in untreated animals, clearly indicating that VCAM-1 is of key importance in mediating adhesion to the endothelial lining in the RPA response. This decrease in adhesion was associated with a significant reduction in leukocyte emigration. This may be as a result of the reduction in adhesion, or alternatively it may indicate that the role of VCAM-1 extends to a direct involvement in mediating leukocyte exit from the vasculature. Given that neutrophils, which express only low levels of the VCAM-1 ligand the 4ß1 integrin, are the dominant leukocyte population that enter the tissue, the prominent role for VCAM-1 may be difficult to explain. However there is a growing body of evidence that neutrophils can use 4ß1 and VCAM-1 to adhere to the endothelial lining and emigrate into tissues.38
Unstimulated murine neutrophils express functional 4 integrins and can adhere and transmigrate across activated cardiac endothelial cells using the 4ß1/VCAM-1 pathway.39,40
LPS-induced neutrophil infiltration to the liver is reduced by VCAM-1 blockade.41
Indeed, comparable observations have also been made in a model of IC-induced neutrophil recruitment into the lung.42
The current observations add weight to these observations suggesting that the ability of VCAM-1 to recruit neutrophils extends to IC-induced responses in striated muscle.
In this study we used a novel technique for quantitation of selectin expression in the inflamed microvasculature, based on the use of fluorochrome-conjugated mAbs, an approach previously used for qualitative assessment of adhesion molecule expression.24,43
To render this technique more quantitative we co-perfused two antibodies labeled with nonoverlapping fluorochromes: one specific for the adhesion molecule of interest (with Alexa 488) and a control IgG (with Alexa 594). The control antibody was used as an index of nonspecific antibody accumulation remaining after the extensive exsanguination procedure. Using this approach we found that nonspecific antibody accumulation was minimal, occurring in the range of 1 to 5% of the initial vessel loading. The approach of using a nonbinding antibody to account for nonspecific accumulation has been successfully used previously in quantitative assays of adhesion molecule expression in whole tissues.25,27
The results of the present experiments supported the predominant venular restriction of endothelial selectin expression previously observed in response to treatment with tumor necrosis factor-.44
Moreover these studies also demonstrated that in the case of P-selectin, not only did the level of P-selectin expression in individual vessels increase in response to the inflammatory stimulus, but the number of venules displaying detectable P-selectin also increased. It was also noteworthy that the number of vessels in which E-selectin was detectable at the peak of its expression was less than 50% that of P-selectin. These observations illustrate additional differences in the regulation of expression of the endothelial selectins during inflammatory responses.
These experiments also allowed us to examine the distribution and co-localization of OVA and anti-OVA during the development of the RPA response. Using fluorochrome-conjugated OVA we observed that, in the absence of an inflammatory response, OVA exits the vasculature and progressively distributes throughout the tissue. Given that the RPA response is initiated within minutes, this raises the possibility that ICs initially form in perivascular sites, immediately on OVA exiting the vasculature. This concept was supported by our observation of perivascular co-localization of the two proteins in the early stages of the RPA response. However, after 60 minutes, this co-localization was widespread, indicating that ICs subsequently form throughout the extravascular tissue. Furthermore, the exit of OVA from the vasculature appears to be accelerated during the RPA response as a consequence of an increase in leakage of plasma proteins from the microvasculature. This is clearly illustrated by the rapid preferential accumulation of OVA in perivenular sites early in the response, an event not observed in the absence of anti-OVA.
The identification of the site of IC formation in the RPA model raises the question of what is the most appropriate model of IC-induced inflammation. In systemic lupus erythematosus, the archetypal IC-mediated disease, autoantibodies circulate both bound to target antigen (ie, as IC), and as free antibody. However the most damaging effects mediated by ICs are believed to occur when they deposit in vascular beds such as renal glomeruli. Furthermore, some autoantibodies only form IC when they bind to an antigen in a fixed tissue location, eg, the glomerular basement membrane, thus localizing IC formation to a specific vasculature. An alternative to the RPA model for examination of the in vivo effects of ICs is the administration of preformed complexes into the circulation. Using this technique may mimic the circulation of ICs in systemic lupus erythematosus. However, variation in factors such as the size and charge of the IC may make it difficult to control the level of deposition in a specific vasculature.45 In contrast, the RPA model is unlikely to result in significant levels of IC formation in the circulation. However, it does offer the advantage of control over the site of IC formation/deposition, enabling analysis of the effects on the microvasculature.
In recent work, Coxon and colleagues16 demonstrated that immobilized ICs had the capacity of initiating attachment and rapid arrest of neutrophils under physiological flow conditions, in the absence of selectin-mediated tethering. This novel observation raised the possibility that IC-induced leukocyte recruitment would continue to occur even if all adhesion molecules were inhibited or absent. Our direct analysis of the RPA response indicated that VCAM-1 was the dominant molecule in mediating leukocyte adhesion in this response, suggesting that ICs present within the vasculature were not major contributors to leukocyte adhesion in this model. This finding would fit with our observation that OVA/anti-OVA co-localization appeared to occur in perivascular sites, but was not detected within the vasculature. These observations suggest that the putative mechanism of IC-mediated leukocyte capture did not play a significant role in this model of leukocyte recruitment. The absence of this mechanism in the present study may reflect differences between in vitro and in vivo approaches, particularly in the site of IC deposition. However, it is conceivable that in vascular beds such as the glomerulus, in which ICs may be present on the luminal aspect of the vasculature, IC-mediated capture may assume a greater role.
In conclusion, these studies have used direct analysis of the cremasteric microcirculation to demonstrate a dominant role for P-selectin and a transient role for E-selectin in mediating IC-induced leukocyte rolling, as well as a key role for VCAM-1 in mediating adhesion and leukocyte entry into tissue. Future experiments will aim to determine the cytokines responsible for expression of these key adhesion molecules.
|
Acknowledgements |
|---|
|
Footnotes |
|---|
Supported by the National Health and Medical Research Council, Australia (project grant no. 236910).
MJH is a National Health and Medical Research Council RD Wright Fellow.
MUN and NCVDV contributed equally to this study.
Accepted for publication June 27, 2003.
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
4-integrin, P-selectin, and E-selectin in an allergic model of inflammation. J Exp Med 1997, 185:1077-10874-integrin supports leukocyte rolling and adhesion in chronically inflamed postcapillary venules in vivo. J Exp Med 1996, 183:1995-20064-integrin. J Immunol 1999, 163:3441-3448RIII (CD16) deficient mice. Immunity 1996, 5:181-188[Medline]
This article has been cited by other articles:
 |
|
 |
|
  J. Apostolopoulos, M. J. Hickey, L. Sharma, P. Davenport, L. Moussa, W. G. James, J. L. Gregory, A. R. Kitching, M. Li, and P. G. Tipping The cytoplasmic domain of tissue factor in macrophages augments cutaneous delayed-type hypersensitivity J. Leukoc. Biol., April 1, 2008; 83(4): 902 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sumagin and I. H. Sarelius A role for ICAM-1 in maintenance of leukocyte-endothelial cell rolling interactions in inflamed arterioles Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2786 - H2798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Sasmono, A. Ehrnsperger, S. L. Cronau, T. Ravasi, R. Kandane, M. J. Hickey, A. D. Cook, S. R. Himes, J. A. Hamilton, and D. A. Hume Mouse neutrophilic granulocytes express mRNA encoding the macrophage colony-stimulating factor receptor (CSF-1R) as well as many other macrophage-specific transcripts and can transdifferentiate into macrophages in vitro in response to CSF-1 J. Leukoc. Biol., July 1, 2007; 82(1): 111 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Orito, M. Fujimoto, N. Ishiura, K. Yanaba, T. Matsushita, M. Hasegawa, F. Ogawa, K. Takehara, and S. Sato Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 cooperatively contribute to the cutaneous Arthus reaction J. Leukoc. Biol., May 1, 2007; 81(5): 1197 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. W. Luscinskas and T. Mayadas Fc{gamma}Rs join in the cascade Blood, May 1, 2007; 109(9): 3615 - 3616. [Full Text] [PDF]
|
|
|
|
|
|
K. J. Lister and M. J. Hickey Immune complexes alter cerebral microvessel permeability: roles of complement and leukocyte adhesion Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H694 - H704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Kuligowski, A. R. Kitching, and M. J. Hickey Leukocyte Recruitment to the Inflamed Glomerulus: A Critical Role for Platelet-Derived P-Selectin in the Absence of Rolling. J. Immunol., June 1, 2006; 176(11): 6991 - 6999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aurrand-Lions, C. Lamagna, J. P. Dangerfield, S. Wang, P. Herrera, S. Nourshargh, and B. A. Imhof Junctional Adhesion Molecule-C Regulates the Early Influx of Leukocytes into Tissues during Inflammation J. Immunol., May 15, 2005; 174(10): 6406 - 6415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Stokol, P. O'Donnell, L. Xiao, S. Knight, G. Stavrakis, M. Botto, U. H. von Andrian, and T. N. Mayadas C1q Governs Deposition of Circulating Immune Complexes and Leukocyte Fc{gamma} Receptors Mediate Subsequent Neutrophil Recruitment J. Exp. Med., October 4, 2004; 200(7): 835 - 846. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
